Cancer immunotherapy exploits our immune system to kill cancerous cells. Recently, researchers have discovered a novel way to do this. They engineered cells that are programmed to die and injected them into tumor. They have successfully shown that the dying cells is able to kill tumor cells via recruitment of the immune system. This strategy might be a potential new method to improve the efficacy of current cancer immunotherapy methods. Continue reading The New Trojan Horse: Using tumor cells to kill tumors